JAK2 and acute myeloid leukemia: The number of cases with JAK2 mutations were small in this study and had variable prognosis with transformation to acute myeloid leukemia in a case, hence in our opinion committing to any definitive conclusion about the prognostic relevance of such mutations and providing definitive management guidelines would be challenging and needs more multi-institutional collaborative studies on a larger sample of cases.